The company confirmed this morning that NICE has taken the "unusual decision" to hold a third appraisal committee meeting as ...

"The residents of Florida must be better educated on the importance of brain health and on reducing the risk of dementia" ...

Additional evidence has prompted NICE to launch a second consultation on its decision not to recommend new Alzheimer’s ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...

Columbia University researchers find a connection between periodontal disease and brain changes linked to Alzheimer’s, ...

For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

The lack of research on Alzheimer’s is worrisome for people like Ben Koenigs. He believes research is vital to find a cure for the devastating disease.

We recently compiled a list of the 12 AI Stocks Making Headlines: Latest News and Ratings. In this article, we are going to ...

Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...